Evogene Schedules Third Quarter 2024 Financial Results Release
Evogene Schedules Third Quarter 2024 Financial Results Release
To join the conference, please register in advance:Zoom conference call scheduled for November 21, 2024, 9:00 AM ET
Zoom視頻會議已安排在2024年11月21日上午9點（美國東部時間）
REHOVOT, Israel, Nov. 7, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the third quarter of 2024, on Thursday, November 21, 2024.
以色列REHOVOT，2024年11月7日 / PRNewswire / - evogene公司（納斯達克：evogene）（TASE：evogene），一家領先的計算生物學公司，旨在革新生命科學產品的發現和開發，今天宣佈將於2024年11月21日星期四發佈2024年第三季度財務業績。
Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).
當天晚些時候，公司管理團隊將在東部時間上午9點（以色列時間下午4點）舉行電話會議討論業績。
To join the conference, please register in advance:
要參加會議，請提前註冊：
The entire conference will be available online on the company's website a few days after.
整個會議將幾天後在公司網站上線。
About Evogene:
關於Evogene：
Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.
Evogene Ltd. (納斯達克: EVGN，特拉維夫證券交易所: EVGN)是一家計算生物學公司，利用大數據和人工智能，旨在通過利用先進技術來提高成功率、縮短開發時間和降低成本，從而徹底改變基於生命科學的產品開發。
Evogene established three unique tech-engines - MicroBoost AI, ChemPass AI and GeneRator AI. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).
Evogene建立了三個獨特的技術引擎——MicroBoost AI、ChemPass AI和GeneRator AI。每個技術引擎都專注於基於以下核心元素之一的產品的發現和開發：微生物（MicroBoost AI）、小分子（ChemPass AI）和基因元件（GeneRator AI）。
Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its four subsidiaries including:
evogene利用其技術引擎通過戰略合作伙伴關係和合作開發產品，旗下有四個子公司，包括：
- Biomica Ltd. () - developing and advancing novel microbiome-based therapeutics to treat human disorders powered by MicroBoost AI;
- Lavie Bio Ltd. () - developing and commercially advancing, microbiome-based ag-biologicals powered by MicroBoost AI;
- AgPlenus Ltd. () - developing next-generation ag chemicals for effective and sustainable crop protection powered by ChemPass AI;
- Casterra Ag Ltd. () - developing and marketing superior castor seed varieties producing high yield and high-grade oil content on an industrial scale for the biofuel and other industries powered by GeneRator AI.
- Biomica有限公司() - 開發和推進新型基於微生物組的治療方法，以MicroBoost AI爲支持。
- Lavie Bio有限公司() - 開發和商業推進，基於微生物組的農業生物製品，由MicroBoost AI提供支持。
- AgPlenus有限公司() - 開發下一代高效可持續作物保護的農業化學品，由ChemPass AI提供支持。
- Casterra Ag有限公司() - 開發和推廣優質蓖麻籽品種，產量高且油質優良，在工業規模上爲生物燃料和其他行業提供支持，由GeneRator 人工智能提供支持。
For more information, please visit: .
欲了解更多信息，請訪問:
Logo -
Logo -
Contact
[email protected]
Tel: +972-8-9311901
聯繫方式
[email protected]
電話：+972-8-9311901
SOURCE Evogene
Evogene信息來源
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎？
譯文內容由第三人軟體翻譯。
